Hikma Pharma To Acquire Parts Of Xellia Pharma's US Finished Dosage Form Business And Assets

(RTTNews) - Hikma Pharmaceuticals (HIK, HIK.L) has agreed with Xellia Pharmaceuticals to acquire parts of its US finished dosage form business and assets, including a commercial portfolio and pipeline of differentiated products, a manufacturing facility in Cleveland, Ohio, sales https://www.nasdaq.com/articles/hikma-pharma-acquire-parts-xellia-pharmas-us-finished-dosage-form-business-and-assets